bioRxiv Science⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2025.07.02.662800

Allelic Variation in CYP3A4 and PLB1 Drives Feed Efficiency and Immunometabolic Resilience in Beef Cattle

Morenikeji, O. B.·Taiwo, G.·Idowu, M.·Gratz, L. M.·Olabosoye, B.·King, R. E.·Andrews, N. D.·Saccoh, F.·Grytsay, A.·Ogunade, I.
View original source ↗Export metadata ↓

Abstract

We evaluated genetic markers for feed efficiency and immunocompetence in 108 crossbred steers (217 {+/-} 8.2 kg) fed a high-forage total mixed ration for 35 days, using GrowSafe8000 intake nodes to calculate residual feed intake (RFI). From the 20 most efficient (low-RFI) and 20 least efficient (high-RFI) animals, we genotyped three metabolic loci (CYP3A4 rs438103222, PLB1 rs456635825, CRAT rs876019788) and profiled blood mRNA levels of these plus eight innate/adaptive immune genes. Logistic regression revealed that CYP3A4 and PLB1 polymorphisms--but not CRAT--were strongly associated with initial and final body weight, average daily gain, and feed intake: CYP3A4 A/A and PLB1 A-allele carriers achieved superior growth on reduced feed. Haplotype reconstruction across the three loci defined eight multi-SNP combinations, with the C-A-A haplotype enriched in low-RFI steers and combinations harboring CYP3A4 A and PLB1 A alleles linked to low RFI. Intriguingly, these favorable genotypes also overlapped with up-regulation of immune sensors and effectors (e.g., CD14, TLR4, TNF-), indicating a coordinated metabolic-immune adaptation in efficient cattle. Collectively, our results validate CYP3A4 and PLB1 as high-impact quantitative trait nucleotides for marker-assisted selection aimed at simultaneously improving feed efficiency and immune resilience in beef production.

Source connections

Explore related subjects

geneticsPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Morenikeji, O. B., Taiwo, G., Idowu, M., Gratz, L. M., Olabosoye, B., King, R. E., Andrews, N. D., Saccoh, F., Grytsay, A., Ogunade, I.. 2025-07-08. Allelic Variation in CYP3A4 and PLB1 Drives Feed Efficiency and Immunometabolic Resilience in Beef Cattle. https://doi.org/10.1101/2025.07.02.662800

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗
bioRxiv2026

Mechanism-selective deep mutational scanning distinguishes ERCC2 disease phenotypes

Pathogenic ERCC2 variants cause xeroderma pigmentosum (XP), trichothiodystrophy (TTD) or both, yet variant effect scores are usually interpreted only as measures of pathogenicity rather than of which disease mechanism is disrupted. XPD, the ERCC2-encoded TFIIH subunit, functions in both nucleotide excision repair and transcription. Using yeast complementation deep mutational scanning, we measured the effects of nearly all XPD amino acid substitutions. The assay was mechanism-selective: it preferentially reported transcription-associated function, with pronounced intolerance at the p44 interface, whereas many substitutions affecting DNA binding and helicase activity retained near-wild-type fitness. Accordingly, TTD variants had much lower fitness than XP variants. Computational predictors discriminated pathogenic from benign variants similarly across phenotypes, but the DMS distinguished XP from TTD variants better than all 73 predictors tested. Phenotype-specific ACMG/AMP calibration provided evidence in both directions for TTD but mainly pathogenic evidence for XP. Thus, the selectivity of functional assays, often viewed as a limitation, can reveal disease mechanisms and support phenotype-aware variant interpretation.

genetics↗
bioRxiv2026

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗